Directive 2012/26/EU of the European Parliament and of the Council of 25 October 2012 amending Directive 2001/83/EC as regards pharmacovigilance
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XIII Medicinal Products
Joint committee decision (JCD)
160/2013 In force in the EEA
Yes Legal documents
Directive 2012/26/EU of the European Parliament and of the Council of 25 October 2012 amending Directive 2001/83/EC as regards pharmacovigilance
Tilskipun Evrópuþingsins og ráðsins 2012/26/ESB frá 25. október 2012 um breytingu á tilskipun 2001/83/EB að því er varðar lyfjagát
Richtlinie 2012/26/EU des Europäischen Parlaments und des Rates vom 25. Oktober 2012 zur Änderung der Richtlinie 2001/83/EG hinsichtlich der Pharmakovigilanz
Europaparlaments- og rådsdirektiv 2012/26/EU av 25. oktober 2012 om endring av direktiv 2001/83/EF med hensyn til legemiddelovervåking
History
01.06.2014
Adopted JCD confirmed entry into force date
01.06.2014
Compliance date in the EEA
29.04.2014
Constitutional requirements under Art. 103 fulfillment date (FL)
Liechtenstein
08.10.2013
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
17.06.2013
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
25.10.2012
Adoption date in the EU
28.10.2013
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.